Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Arbor Biotechnologies
company
About
Arbor Biotechnologies is an operator of a bio-discovery company intended to provide human diagnostic development services.
- 51 - 100
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $215M
- Industries
- Biopharma,Biotechnology,Life Science
- Founded date
- Jan 1, 2016
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Arbor Biotechnologies is an operator of a bio-discovery company intended to provide human diagnostic development services. The company's platform employs a diverse set of technologies and techniques including artificial intelligence, genome sequencing, gene synthesis, and high-throughput screening, enabling drug developers to accelerate the discovery of proteins for improving human health and sustainability.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$230.60M
Arbor Biotechnologies has raised a total of
$230.60M
in funding over 2 rounds. Their latest funding was raised on
Nov 9, 2021 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Nov 9, 2021 | Series B | $215M | 1 | — | — | Detail |
| Jun 1, 2017 | Series A | $15.60M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Arbor Biotechnologies is funded by 1 investors.
ARCH Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
ARCH Venture Partners
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
